EXPERIMENTAL-MODEL OF DOXORUBICIN EXTRAVASATION IN THE MOUSE

被引：32

作者：

DORR, RT

ALBERTS, DS

CHEN, HSG

机构：

[1] UNIV ARIZONA,SCH PHARM,DEPT PHARMACEUT CHEM,TUCSON,AZ 85724

[2] UNIV ARIZONA,SCH MED,DIV CANC CTR,TUCSON,AZ 85724

来源：

JOURNAL OF PHARMACOLOGICAL METHODS | 1980年 / 4卷 / 03期

关键词：

D O I：

10.1016/0160-5402(80)90016-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：237 / 250

页数：14

共 23 条

[1] CELL KINETIC-MODEL TO EXPLAIN THE TIME OF APPEARANCE OF SKIN REACTION AFTER X-RAYS OR ULTRAVIOLET-LIGHT IRRADIATION [J].

ALBARWARI, SE ;

POTTEN, CS .

CELL AND TISSUE KINETICS, 1979, 12 (03) :281-289

[2] NURSING MANAGEMENT OF ADRIAMYCIN EXTRAVASATION [J].

BARLOCK, AL ;

HOWSER, DM ;

HUBBARD, SM .

AMERICAN JOURNAL OF NURSING, 1979, 79 (01) :94-96

[3] ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].

BLUM, RH ;

CARTER, SK .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259

[4] ADRIAMYCIN EXTRAVASATION [J].

BOWERS, DG ;

LYNCH, JB .

PLASTIC AND RECONSTRUCTIVE SURGERY, 1978, 61 (01) :86-92

[5]

BRISTOW MR, 1979, P AM ASSOC CANC RES, V20, P118

[6]

BROWN VKH, 1971, J SOC COSMET CHEM, V22, P411

[7]

COHEN H, 1979, CANCER TREAT REP, V63, P1003

[8] FACTORS AFFECTING PENTOSE PHOSPHATE PATHWAY ACTIVITY IN HUMAN RED-CELLS [J].

DAVIDSON, WD ;

TANAKA, KR .

BRITISH JOURNAL OF HAEMATOLOGY, 1972, 23 (03) :371-&

[9]

Frankfurt O. S., 1968, Experimental Cell Research, V52, P220

[10]

HENRY DW, 1979, CANCER TREAT REP, V63, P845

← 1 2 3 →